Class Examples named by WADA Status GHRH analogs CJC-1293, CJC-1295, sermorelin, tesamorelin S2 prohibited at all times GH secretagogues and mimetics Anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin, tabimorelin S2 prohibited at all times GH-releasing peptides (GHRPs) Alexamorelin, examorelin (hexarelin), GHRP-1, GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-6 S2 prohibited at all times Erythropoietin and EPO-receptor agonists Erythropoietins and agents affecting erythropoiesis S2 prohibited at all times Growth hormone and growth factors Growth hormone, IGF-1 and its analogs, and related growth factors affecting muscle, tendon or ligament S2 prohibited at all times Unapproved experimental peptides BPC-157 and similar compounds with no regulatory approval S0 prohibited at all times The S0 point is the one most often missed
Your dose may need to go up based on tolerance and response, but your price won'tPlexusDx charges one flat monthly rate regardless of your dose level
You cannot choose to lose fat only from your stomach, arms, thighs, or another specific area with a treatment that works throughout the body
Your weight loss has plateaued: If your weight loss stalls for several weeks despite consistent diet changed and increased physical activity along with your medication, a higher dose may be needed to re-stimulate your metabolism and appetite suppression
A provider that approves all applicants regardless of their health information is not conducting a genuine assessment
When managing diabetes, it is essential to distinguish between different drug classes that may cause confusion due to similar-sounding names
